Abstract
Background
Presence of contrast agent in the urinary system in infants after small-bowel follow-through study with low-osmolar contrast media has been described as a sign of bowel perforation.
Objective
To evaluate how often the presence of contrast agent in the bladder after small-bowel follow-through is a reliable sign of bowel perforation or necrosis.
Materials and methods
From the radiology information system, we retrieved imaging reports of infants evaluated with small-bowel follow-through and findings of contrast agent in the bladder. We retrieved demographic and clinical information from the medical records. Presence of bladder contrast medium was considered true-positive evidence of bowel perforation or necrosis if confirmed by pneumoperitoneum, extraluminal contrast agent, surgery or pathology within 3 days of the small-bowel follow-through. False-positives for bowel perforation or necrosis were based on surgical findings or clinical follow-up.
Results
Of the 207 infants who had small-bowel follow-through, 18 infants (12 boys; mean age 50 days, range 14 days to 8.5 months) had contrast medium in the bladder after the small-bowel follow-through. Fifteen of the 18 (83.3%) had a history of prematurity and 11 had prior abdominal surgery. Four of the 18 (22.2%) had bowel perforation or necrosis at surgery or pathology performed more than 3 days after the small-bowel follow-through and were considered indeterminate and excluded. Eight of the remaining 14 infants (57.1%) had bowel perforation or necrosis based on surgical evidence of perforation or pathology confirmation of necrosis (n=6), pneumoperitoneum (n=1) or contrast agent leakage from enterocutaneous fistula (n=1). Six of the 14 (42.9%) were false-positives, without evidence of bowel perforation or necrosis based on clinical follow-up (n=4) or surgery (n=2).
Conclusion
Demonstration of urinary contrast agent post small-bowel follow-through with low-osmolar contrast medium in newborns/infants with complex medical problems is not a definitive indication of bowel perforation or necrosis. More than one-third of our patients with contrast medium in the bladder did not have bowel perforation or necrosis.
Similar content being viewed by others
References
Callahan MJ, Talmadge JM, MacDougall RD et al (2017) Selecting appropriate gastroenteric contrast media for diagnostic fluoroscopic imaging in infants and children: a practical approach. Pediatr Radiol 47:372–381
Clarke EA, Dutton NE (1988) Use of iohexol in the early determination of gastrointestinal perforation. J Pediatr Surg 23:1027–1028
Mori PA, Barrett HA (1962) A sign of intestinal perforation. Radiology 79:401–407
Douglas JB, Kerr IH (1968) Urinary excretion of Gastrografin in abdominal emergencies. Br J Radiol 41:429–431
Hay M, Cant PJ (1990) Renal excretion of enteral Gastrografin in the absence of free intestinal perforation. Clin Radiol 41:137–138
Apter S, Gayer G, Amitai M, Hertz M (1998) Urinary excretion of orally ingested Gastrografin on CT. Abdom Imaging 23:297–300
Jones AR, Campbell SH (1992) Case report: renal excretion of Gastrografin following rectal administration. Clin Radiol 46:348–349
Cohen MD, Schreiner R, Grosfeld J et al (1983) A new look at the neonatal bowel-contrast studies with metrizamide (Amipaque). J Pediatr Surg 18:442–448
Halme L, Edgren J, Turpeinen U et al (1997) Urinary excretion of iohexol as a marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 32:148–152
Rencken IO, Sola A, al-Ali F et al (1997) Necrotizing enterocolitis: diagnosis with CT examination of urine after enteral administration of iodinated water-soluble contrast material. Radiology 205:87–90
Cohen MD, Jansen R, Lemons J, Schreiner R (1984) Evaluation of the gasless abdomen in the newborn and young infant with metrizamide. AJR Am J Roentgenol 142:393–396
Cohen MD, Weber TR, Grosfeld JL (1984) Bowel perforation in the newborn: diagnosis with metrizamide. Radiology 150:65–69
Cohen MD, Schreiner R, Lemons J (1982) Neonatal pneumoperitoneum without significant adventitious pulmonary air: use of metrizamide to rule out perforation of the bowel. Pediatrics 69:587–589
Laerum F, Stordahl A, Solheim KE et al (1991) Intestinal follow-through examinations with iohexol and iopentol. Permeability alterations and efficacy in patients with small bowel obstruction. Investig Radiol 26:S177–S181
Andersen R, Laerum F, Bay D et al (1992) Experimental colonic inflammation and ulceration. Permeation of a water-soluble contrast medium as a measure of “disease” activity. Scand J Gastroenterol 27:757–763
Stordahl A (1989) Water-soluble contrast media in obstructed in ischemic small intestine. A clinical and experimental study. J Oslo City Hosp 39:3–22
Kim HS, Je BK, Cha SH et al (2014) Renal excretion of water-soluble contrast media after enema in the neonatal period. Pediatr Neonatol 55:256–261
Poole CA, Rowe MI (1976) Clinical evidence of intestinal absorption of Gastrografin. Radiology 118:151–153
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Karmazyn, B., Wanner, M.R., Bhatia, M. et al. Urinary excretion of low-osmolar contrast media during small-bowel follow-through studies in infants is not definitive evidence of bowel perforation. Pediatr Radiol 53, 210–216 (2023). https://doi.org/10.1007/s00247-022-05463-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-022-05463-y